Oxurion NV (EBR:OXUR)

Belgium flag Belgium · Delayed Price · Currency is EUR
0.0030
0.00 (0.00%)
Jun 11, 2026, 12:54 PM CET
Market Cap266.07K -37.6%
Revenue (ttm)555.00K +18,400.0%
Net Income-3.73M
EPS-0.13
Shares Out 88.69M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume500,000
Open0.0030
Previous Close0.0030
Day's Range0.0030 - 0.0030
52-Week Range0.0028 - 0.0840
Beta-0.15
Analystsn/a
Price Targetn/a
Earnings DateSep 30, 2026

About Oxurion NV

Oxurion NV, a biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium. The company is developing ophthalmic treatments to preserve vision for patients geographic atrophy and wet age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1991
Employees 26
Stock Exchange Euronext Brussels
Ticker Symbol OXUR
Full Company Profile

Financial Performance

Financial Statements